ARRIVI, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 602
NA - Nord America 378
AS - Asia 175
SA - Sud America 14
AF - Africa 8
OC - Oceania 1
Totale 1.178
Nazione #
IT - Italia 423
US - Stati Uniti d'America 370
SG - Singapore 111
DE - Germania 33
RU - Federazione Russa 32
FI - Finlandia 25
ID - Indonesia 19
IN - India 19
SE - Svezia 17
CN - Cina 15
GB - Regno Unito 13
BR - Brasile 12
AT - Austria 11
NL - Olanda 8
CA - Canada 7
FR - Francia 7
BE - Belgio 6
AL - Albania 5
BG - Bulgaria 5
NG - Nigeria 5
GR - Grecia 4
HK - Hong Kong 4
IE - Irlanda 4
RO - Romania 3
CH - Svizzera 2
TG - Togo 2
TR - Turchia 2
UA - Ucraina 2
AR - Argentina 1
EG - Egitto 1
KG - Kirghizistan 1
MX - Messico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 1.178
Città #
Rome 132
Singapore 77
Fairfield 56
Santa Clara 49
Milan 42
Ashburn 30
Helsinki 22
Woodbridge 22
Jakarta 18
Chandler 16
Houston 16
Wilmington 15
Cambridge 12
Nuremberg 12
Boardman 11
Falkenstein 10
Florence 10
Seattle 10
Naples 9
Signa 9
Vienna 9
Moscow 8
New York 8
San Paolo di Civitate 8
Cappelle sul Tavo 7
Princeton 7
Brussels 6
London 6
Paris 6
Ann Arbor 5
Lagos 5
Ottawa 5
Pescara 5
Piazza Armerina 5
Pune 5
Sofia 5
Beijing 4
Corsico 4
Dublin 4
Hong Kong 4
Lawrence 4
Marcon 4
Millbury 4
Palermo 4
Turin 4
Albenga 3
Bari 3
Birmingham 3
Bologna 3
Bremen 3
Fonte Nuova 3
Frankfurt am Main 3
Genoa 3
Lappeenranta 3
Rho 3
San Diego 3
Vicenza 3
Wuhan 3
Yubileyny 3
Ancona 2
Andover 2
Athens 2
Bagheria 2
Bisceglie 2
Boydton 2
Calvanico 2
Castano Primo 2
Castellanza 2
Cavallino 2
Chivasso 2
Colorno 2
Crispiano 2
Dearborn 2
Fano 2
Ferrara 2
Genazzano 2
Giovinazzo 2
Grugliasco 2
Imola 2
Kunming 2
Lamezia Terme 2
Lavagna 2
Lomé 2
Los Angeles 2
Naro 2
New Delhi 2
Novoli 2
Palestrina 2
Romola 2
Sinalunga 2
Toronto 2
Velletri 2
Verucchio 2
West Jordan 2
Amsterdam 1
Araras 1
Barnet 1
Bergamo 1
Betim 1
Biguaçu 1
Totale 832
Nome #
Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis 126
Drug–drug interactions and pharmacogenomic evaluation in colorectal cancer patients. The new drug-pin® system comprehensive approach 124
Evaluation of prognostic factors for survival in transverse colon cancer 87
Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study 80
Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center 71
Sequential treatment with regorafenib and trifluridine/tipiracil in later-line refractory metastatic colorectal cancer: A real-world multicenter retrospective study 65
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference 65
The potential role of genomic signature in stage II relapsed colorectal cancer (CRC) patients: a mono-institutional study 53
null 49
Diagnostic and therapeutic management of primary orbital neuroendocrine tumors (NETs): systematic literature review and clinical case presentation 48
The management of oligometastatic disease in colorectal cancer: present strategies and future perspectives 38
Is CT radiomics superior to morphological evaluation for pN0 characterization? A pilot study in colon cancer 34
Necrolytic migratory erythema impact on prognosis and diagnosis of glucagonoma: a case report 33
398P Effectiveness and safety of regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A real-world multicenter retrospective study with focus on sequential treatment 32
Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach 30
The evolving impact of genomic biomarker landscape in stage II colorectal cancer (CRC). 27
Treatment settings and outcomes with Regorafenib and Trifluridine/Tipiracil at third-line treatment and beyond in metastatic colorectal cancer: a real-world multicenter retrospective study 27
Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single-center retrospective analysis 23
Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study 21
Management of overlapping immune-related myocarditis, myositis, and myasthenia in a young patient with advanced NSCLC: a case report 19
Leptomeningeal carcinomatosis in early gastric cancer: a case report and literature review 18
Updated results of a phase II randomized trial with high dose proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumours 18
P-195 Influence of age on disease control rate of patients treated with regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A multicenter retrospective real-world study 18
Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient 18
Oligoprogression during Abiraterone therapy treated with radiotherapy in mCRPC patients. 17
Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis 16
Gastroenteropancreatic Neuroendocrine Neoplasms (GEP NENs). The Role of Checkpoint Inhibitors 15
Survival benefit with regorafenib and/or trifluridine/tipiracil sequencing to rechallenge with anti-EGFR-based third-line regimens in metastatic colorectal cancer: A multicenter retrospective real-world subgroups comparison 14
Efficacy of regorafenib and trifluridine/tipiracil according to extended RAS evaluation in advanced metastatic colorectal cancer patients: a multicenter retrospective analysis 14
The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets 14
Exploring carcinoid syndrome in neuroendocrine tumors: insights from a multidisciplinary narrative review 12
Studio di identificazione di fattori prognostici e predittivi nell’ambito del tumore del colon retto: dagli stadi iniziali alla malattia metastatica 11
Resectable gastric cancer: should we apply a tailored surgical strategy according to microsatellite status? 11
Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient 10
73P Efficacy outcomes in ≥70-year-old or younger patients receiving regorafenib-to-trifluridine/tipiracil sequence or vice versa for refractory metastatic colorectal cancer: Findings from the multicenter retrospective “ReTrITA” study 10
Survival Outcomes with Regorafenib and/or Trifluridine/Tipiracil Sequencing to Rechallenge with Third-Line Regimens in Metastatic Colorectal Cancer: A Multicenter Retrospective Real-World Subgroup Comparison from the ReTrITA Study 9
Sidedness and Molecular Pattern in Defining the Risk of Lymph Node Metastasis in Nonmetastatic Colorectal Cancer: Single-Center Retrospective Study 6
The efficacy of streptozotocin in managing pancreatic neuroendocrine neoplasms – A systematic review 2
Totale 1.285
Categoria #
all - tutte 5.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.900


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202040 0 0 0 0 0 0 0 0 14 6 8 12
2020/202149 3 3 6 0 7 2 0 3 12 0 2 11
2021/2022113 0 3 5 3 8 11 0 13 4 10 46 10
2022/2023176 10 19 8 7 18 10 4 29 34 8 20 9
2023/2024318 17 27 8 24 26 45 15 34 7 44 33 38
2024/2025528 31 42 45 90 76 81 60 74 29 0 0 0
Totale 1.285